An immunofluorescence (FA) technique has been developed which can identify herpes simplex virus (HSV) in clinical specimens and also type the virus directly as type 1 Human clinical specimen studies. Table 3 summarizes the number of cases in which FA and cultures were both positive or both negative, as well as instances in which one technique yielded positive and the other yielded negative results, or vice versa. Of 76 cases positive by culture methods, 16 were negative by FA, indicating a sensitivity of 80%. It should be noted, however, that of 28 specimens with inadequate cells for staining, 16 were positive by culture; if these are included, the sensitivity of the FA test would be 65%. Of the 60 FA-positive cases, only 1 disagreed with culture results regarding HSV type. There were also 6 specimens which were negative by culture of 66 which were found to be positive with the FA technique, indicating a specificity of 91 %.
DISCUSSION
Any method attempting to demonstrate HSVinduced changes in cells, such as cytological or immunofluorescence techniques, is beset with the problem of obtaining adequate smears. This problem is not only one of having a sufficient number of cells of any kind on the slide but also of having enough virus-infected cells on the smears to be examined. In previous studies attempting to isolate HSV from clinical specimens by culture methods, we have found that the most adequate specimens are those obtained from fresh herpetic vesicles before their ulceration (7) . With immunofluorescence methods, it becomes additionally important to obtain cells which contain detectable virus (around 6 to 40 hr after initial infection of the cell).
It is difficult to know, therefore, how many of the 16 specimens with positive cultures, but negative FA results, contained a sufficient number of cells at the right stage of infection (Table 3) . It should be noted that 28 specimens, of which 16 were positive by culture, in addition to the 185 recorded in Table 2 , had been received with such low numbers of cells that it was not possible to perform an adequate FA test. The interval between the time of obtaining the clinical specimen and performing the FA test may have also influenced the results. In several instances, in both the mouse and human specimens, the culture-positive, FA-negative slides included cases in which the FA test was performed more than 1 month after collection of the original specimen.
The mouse data also suggest that the FA technique may detect HSV in specimens with negative culture isolations. In a corollary study (10) which compared shipment of clinical specimens in Hanks BSS in dry ice with three other transport media shipped at ambient temperature, virus could not be isolated from about 10% of specimens obtained in Hanks which were positive in one or more of the other media. In the present study, five of the six specimens with positive FA tests and negative cultures (Table 2) were obtained from cases with typical herpetic infections. It should also be noted that the virus type in the six specimens was that which would be anticipated on the basis of site of infection (5, 6) . Thus, the two type 2 FA-positive, culture-negative specimens originated from penile or cervical lesions, and the four type 1 FA-positive, culture-negative specimens originated from mouth or lips and skin above the waist. The 1 case of 60 in which the FA typing result did not corroborate the culture results may be attributed to the problem that two areas on one slide may have different numbers of infected cells. The recent availability of more specific conjugates (Sa) for type 1 and type 2 herpes might preclude this difficulty in the future.
The increasing need for ready availability of laboratory confirmation and typing of HSV from skin, genital, and other sites is based on recent clinical differentiation between the two HSV types (6, 8) . The expanding role of genital herpes as a venereal disease and as a possible cause of fetal and newborn infections and its possible association to cervical cancer have increased the need for such improved laboratory tests. The advent of possible antiviral chemotherapy for serious HSV infections (4a) and the possible difference in the susceptibility of the two HSV types to some of the antiviral drugs (14) have also stimulated efforts to obtain rapid HSV diagnosis and typing. Such 
